|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016011,
umls-concept:C0021107,
umls-concept:C0027051,
umls-concept:C0030705,
umls-concept:C0038257,
umls-concept:C0205210,
umls-concept:C0220922,
umls-concept:C0574032,
umls-concept:C0679199,
umls-concept:C1269765,
umls-concept:C1274040,
umls-concept:C1522577,
umls-concept:C1999216,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-7-9
|
|
pubmed:abstractText |
We sought to investigate whether the previously reported midterm clinical benefit of planned sirolimus-eluting stent (SES) implantation in patients with ST-segment elevation myocardial infarction (STEMI) was maintained over a 24-month time period. Moreover, the distribution of clinical events in relation to thienopyridine discontinuation was thoroughly investigated.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
138-45
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17616297-Aged,
pubmed-meshheading:17616297-Aged, 80 and over,
pubmed-meshheading:17616297-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17616297-Antibodies, Monoclonal,
pubmed-meshheading:17616297-Combined Modality Therapy,
pubmed-meshheading:17616297-Coronary Restenosis,
pubmed-meshheading:17616297-Disease-Free Survival,
pubmed-meshheading:17616297-Drug Delivery Systems,
pubmed-meshheading:17616297-Female,
pubmed-meshheading:17616297-Follow-Up Studies,
pubmed-meshheading:17616297-Humans,
pubmed-meshheading:17616297-Immunoglobulin Fab Fragments,
pubmed-meshheading:17616297-Male,
pubmed-meshheading:17616297-Middle Aged,
pubmed-meshheading:17616297-Myocardial Infarction,
pubmed-meshheading:17616297-Platelet Aggregation Inhibitors,
pubmed-meshheading:17616297-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:17616297-Proportional Hazards Models,
pubmed-meshheading:17616297-Prosthesis Design,
pubmed-meshheading:17616297-Risk,
pubmed-meshheading:17616297-Sirolimus,
pubmed-meshheading:17616297-Stents,
pubmed-meshheading:17616297-Tyrosine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study.
|
|
pubmed:affiliation |
Institute of Cardiology, University of Ferrara, Ferrara, Italy. vlgmrc@unife.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
